8-K
Current Report
Spyre Therapeutics, Inc. Filed Acc 0001193125-17-200086
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d412073d8k.htm…